Search Results - "Maticic, M."

Elimination of hepatitis C in Europe: can WHO targets be achieved? by Matičič, M., Lombardi, Andrea, Mondelli, Mario U., Colombo, Massimo

“…Chronic hepatitis C virus (HCV) infection affects 71 million people worldwide. The availability of highly efficient direct-acting antivirals has revolutionized…”
Get full text

We know DAAs work, so now what? Simplifying models of care to enhance the hepatitis C cascade by Lazarus, J. V., Pericàs, J. M., Picchio, C., Cernosa, J., Hoekstra, M., Luhmann, N., Maticic, M., Read, P., Robinson, E. M., Dillon, J. F.

“…Globally, some 71 million people are chronically infected with hepatitis C virus (HCV). Marginalized populations, particularly people who inject drugs (PWID),…”
Get full text

Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study

“…Since the release of the first global hepatitis elimination targets in 2016, and until the COVID-19 pandemic started in early 2020, many countries and…”
Get more information

Ureaplasma parvum and Ureaplasma urealyticum detected with the same frequency among women with and without symptoms of urogenital tract infection by Marovt, M., Keše, D., Kotar, T., Kmet, N., Miljković, J., Šoba, B., Matičič, M.

“…There is mounting evidence stating that Ureaplasma urealyticum causes non-gonococcal urethritis in males, whereas Ureaplasma parvum does not seem to be of…”
Get full text

Elimination of viral hepatitis: where do we stand in the year 2020? by Maticic, M., Mondelli, M.U.

Get full text

The benefits of hepatitis C virus cure: Every rose has thorns by Salmon, D., Mondelli, M. U., Maticic, M., Arends, J. E.

“…Summary To examine mid‐term benefits on hepatic complications, extrahepatic clinical syndromes and quality of life associated with HCV cure; to review the few…”
Get full text

Addressing barriers to the prevention, diagnosis and treatment of hepatitis B and C in the face of persisting fiscal constraints in Europe: report from a high level conference by Papatheodoridis, G., Thomas, H. C., Golna, C., Bernardi, M., Carballo, M., Cornberg, M., Dalekos, G., Degertekin, B., Dourakis, S., Flisiak, R., Goldberg, D., Gore, C., Goulis, I., Hadziyannis, S., Kalamitsis, G., Kanavos, P., Kautz, A., Koskinas, I., Leite, B. R., Malliori, M., Manolakopoulos, S., Matičič, M., Papaevangelou, V., Pirona, A., Prati, D., Raptopoulou - Gigi, M., Reic, T., Robaeys, G., Schatz, E., Souliotis, K., Tountas, Y., Wiktor, S., Wilson, D., Yfantopoulos, J., Hatzakis, A.

“…Summary In the WHO–EURO region, around 28 million people are currently living with chronic viral hepatitis, and 120 000 people die every year because of it…”
Get full text

The civil society monitoring of hepatitis C response related to the WHO 2030 elimination goals in 35 European countries by Maticic, M, Pirnat, Z, Leicht, A, Zimmermann, R, Windelinck, T, Jauffret-Roustide, M, Duffell, E, Tammi, T, Schatz, E

“…People who inject drugs (PWID) account for the majority of new cases of hepatitis C virus (HCV) infection in Europe; however, HCV testing, and treatment for…”
Get full text

The present and future disease burden of hepatitis C virus infections with today's treatment paradigm - volume 3 by Sibley, A., Han, K. H., Abourached, A., Lesmana, L. A., Makara, M., Jafri, W., Assiri, A. M., Goldis, A., Abaalkhail, F., Abbas, Z., Abdou, A., Al Braiki, F., Al Hosani, F., Al Jaberi, K., Al Mulla, M. A., Al Quraishi, H., Al Serkal, Y., Alam, A., Alawadhi, S., Aldins, P., Alfaleh, F. Z., Alghamdi, A. S., Al-Hakeem, R., Aljumah, A. A., Almessabi, A., Alqutub, A. N., Alswat, K. A., Altraif, I., Andrea, N., Baqir, A., Barakat, M. T., Bergmann, O. M., Bizri, A. R., Blach, S., Choi, M. S., Djauzi, S., El Hassan, E. S., El Khoury, S., Estes, C., Farooqi, J. I., Fridjonsdottir, H., Gani, R. A., Ghafoor Khan, A., Gheorghe, L., Gregorcic, S., Gunter, J., Hajarizadeh, B., Hamid, S., Hasan, I., Hashim, A., Horvath, G., Hunyady, B., Husni, R., Jeruma, A., Jonasson, J. G., Karlsdottir, B., Kim, D. Y., Koutoubi, Z., Lim, Y. S., Löve, A., Maimets, M., Malekzadeh, R., Matičič, M., Memon, M. S., Merat, S., Mokhbat, J. E., Mourad, F. H., Nugrahini, N., Priohutomo, S., Qureshi, H., Rassam, P., Razavi, H., Razavi-Shearer, K., Rozentale, B., Sadik, M., Saeed, K., Salamat, A., Sanai, F. M., Sanityoso Sulaiman, A., Sayegh, R. A., Sharara, A. I., Siddiq, M., Siddiqui, A. M., Sigurdardottir, B., Speiciene, D., Sulaiman, A., Sultan, M. A., Taha, M., Tanaka, J., Tarifi, H., Tayyab, G., Tolmane, I., Umar, M., Valantinas, J., Videčnik-Zorman, J., Yaghi, C., Yunihastuti, E., Yusuf, M. A., Zuberi, B. F., Schmelzer, J. D.

“…Summary The total number, morbidity and mortality attributed to viraemic hepatitis C virus (HCV) infections change over time making it difficult to compare…”
Get full text

Confirmed inguinal lymphogranuloma venereum genovar L2c in a man who had sex with men, Slovenia, 2015 by Matičič, Mojca, Klavs, Irena, Videčnik Zorman, Jerneja, Vidmar Vovko, Darja, Kogoj, Rok, Keše, Darja

“…A laboratory-confirmed lymphogranuloma venereum (LGV) case in Slovenia was reported in 2015, in a human immunodeficiency virus (HIV)-negative man presenting…”
Get full text

Restrictions on access to direct-acting antivirals for people who inject drugs: The European Hep-CORE study and the role of patient groups in monitoring national HCV responses by Lazarus, J.V., Safreed-Harmon, K., Stumo, S.R., Jauffret-Roustide, M., Maticic, M., Reic, T., Schatz, E., Tallada, J., Harris, M.

“…In 2016, the World Health Organization (WHO) called for the elimination of viral hepatitis as a public health threat and established the ambitious targets of…”
Get full text

Strategies to manage hepatitis C virus infection disease burden - volume 3 by Nugrahini, N., Matičič, M., Tolmane, I., Alzaabi, M., Hajarizadeh, B., Kim, D. Y., Hunyady, B., Abaalkhail, F., Abdou, A., Abourached, A., Al Braiki, F., Al Hosani, F., Al Jaberi, K., Al Khatry, M., Al Mulla, M. A., Al Quraishi, H., Al Serkal, Y., Alam, A., Alavian, S. M., Alawadhi, S., Al-Dabal, L., Aldins, P., Alghamdi, A. S., Al-Hakeem, R., Almessabi, A., Alqutub, A. N., Alswat, K. A., Altraif, I., Andrea, N., Assiri, A. M., Baqir, A., Bergmann, O. M., Bizri, A. R., Chaudhry, A., Choi, M. S., Diab, T., Djauzi, S., El Hassan, E. S., El Khoury, S., Estes, C., Fakhry, S., Farooqi, J. I., Fridjonsdottir, H., Gani, R. A., Ghafoor Khan, A., Gheorghe, L., Goldis, A., Gregorcic, S., Gunter, J., Han, K. H., Hasan, I., Hashim, A., Horvath, G., Husni, R., Jafri, W., Jeruma, A., Jonasson, J. G., Karlsdottir, B., Kim, Y. S., Koutoubi, Z., Lesmana, L. A., Lim, Y. S., Löve, A., Maimets, M., Makara, M., Malekzadeh, R., Memon, M. S., Merat, S., Mourad, F. H., Nawaz, A., Olafsson, S., Priohutomo, S., Qureshi, H., Rassam, P., Razavi, H., Razavi-Shearer, D., Razavi-Shearer, K., Rozentale, B., Sadik, M., Salamat, A., Salupere, R., Sanai, F. M., Sayegh, R. A., Schmelzer, J. D., Sharara, A. I., Sibley, A., Sigmundsdottir, G., Sigurdardottir, B., Speiciene, D., Sultan, M. A., Taha, M., Tanaka, J., Tayyab, G., Ud din, M., Umar, M., Videčnik-Zorman, J., Yaghi, C., Yunihastuti, E., Yusuf, M. A., Zuberi, B. F.

“…Summary The hepatitis C virus (HCV) epidemic was forecasted through 2030 for 15 countries in Europe, the Middle East and Asia, and the relative impact of two…”
Get full text

Access to hepatitis C treatment in Europe: findings from the 2016 Hep-CORE study by Lazarus, J.V, Stumo, S.R, Safreed-Harmon, K, Harmanci, F.H, Harris, M, Hendrickx, G, Jauffret-Roustide, M, Reic, T, Tallada, J, Maticic, M

Get full text

869 ADDITION OF FLUVASTATIN TO STANDARD OF CARE TREATMENT DOES NOT IMPROVE SUSTAINED VIROLOGICAL RESPONSE IN CHRONIC HEPATITIS C GENOTYPE 3 PATIENTS by Selic Kurincic, T, Lesnicar, G, Poljak, M, Meglic Volkar, J, Rajter, M, Prah, J, Baklan, Z, Maticic, M

Get full text

P1188 A CHANGE IN LIFE-STYLE AFTER SUCCESSFUL TREATMENT OF CHRONIC HEPATITIS C IN PEOPLE WHO INJECT DRUGS by Maticic, M, Kastelic, T, Kordiš, P, Oblak, T, Kastelic, A, Meglic-Volkar, J, Rajter, M, Prah, J, Kotar, T, Cuk, J, Rebolj-Kodre, A.-M

Get full text

Lichen planus and other cutaneous manifestations in chronic hepatitis C: pre- and post-interferon-based treatment prevalence vary in a cohort of patients from low hepatitis C virus endemic area by Maticic, M, Poljak, M, Lunder, T, Rener-Sitar, K, Stojanovic, L

“…Background  Several controversies exist regarding the relationship between hepatitis C virus (HCV) infection and some cutaneous manifestations, lichen planus…”
Get full text

Lichen planus in hepatitis C virus infection: an early marker that may save lives by Maticic, Mojca

“…Hepatitis C virus (HCV) represents a major public health problem as a causative agent in developing chronic hepatitis, cirrhosis, and hepatocellular carcinoma…”
Get full text

Peginterferon alfa-2b plus weight-based ribavirin for 24 weeks in patients with chronic hepatitis C virus genotype 1 with low viral load who achieve rapid viral response by Craxi, A., Koutsounas, S., Ogurtsov, P., Chemello, L., Maticic, M., Torras, J., Diago, M., Tartaglione, M. T., Witthoeft, T., Yu, X., Faruqi, R., Chaudhri, E., Pedicone, L. D., Zuckerman, E.

“…In chronic hepatitis C (CHC), treatment duration may be individualized according to time to first undetectable hepatitis C virus (HCV) RNA, with patients who…”
Get full text

Proviral HIV-1 DNA in Gingival Crevicular Fluid of HIV-1-infected Patients in Various Stages of HIV Disease by Matičić, M., Poljak, M., Kramar, B., Tomažić, J., Vidmar, L., Zakotnik, B., Skalerič, U.

“…The oral cavity is rarely reported to be a site of human immunodeficiency virus (HIV) transmission, despite detectable virus in saliva and relatively frequent…”
Get full text

Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia by Kese, D., Maticic, M., Potocnik, M.

“…This study assessed the age and gender distribution of Chlamydia trachomatis infections among patients attending two clinics for sexually transmitted diseases…”
Get full text